Login / Signup

Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial.

Yongliang FengJing ChenTian YaoYue ChangXiaoqing LiRongqin XingHong LiRuixue XieXiaohong ZhangZhiyun WeiShengcai MuLing LiuLizhong FengSuping Wang
Published in: Infectious diseases of poverty (2021)
Chinese Clinical Trial Registry, ChiCTR2100041705, ChiCTR2100041706. Registered 1 January 2021, www.chictr.org.cn .
Keyphrases
  • clinical trial
  • sars cov
  • phase ii
  • open label
  • study protocol
  • double blind
  • phase iii
  • respiratory syndrome coronavirus
  • lymph node metastasis
  • randomized controlled trial
  • squamous cell carcinoma